EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy

Haochen Zhao iD, Qian Jiang, Quanji Wang, Zihan Wang, Yimin Huang, Ting Lei iD

Cells · 2026

DOI: 10.3390/cells15050409 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Haochen Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sino-German Neuro-Oncology Molecular Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030…. Hauptthemen laut MEDLINE: Anticonvulsants, Drug Repositioning, Epilepsy, Central Nervous System Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Celarts Bioscience Group Co. Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiepileptic drugs (AEDs) are primarily indicated for controlling epileptic seizures. However, accumulating clinical evidence suggests that their benefits in patients with central nervous system (CNS) tumors extend beyond seizure management. Emerging evidence indicates that AEDs possess direct antitumor activity independent of their antiepileptic effects, highlighting a promising novel direction for CNS tumor therapy. This review elucidates the multifaceted antitumor mechanisms of classic (e.g., valproic acid and levetiracetam) and novel (e.g., cannabidiol) AEDs, including their impacts on metabolic reprogramming, epigenetic regulation, endoplasmic reticulum stress and unfolded protein response (ERS-UPR), ion homeostasis, and the tumor immune microenvironment (TIME) to provide new insights and a theoretical basis for developing multitarget therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsDrug RepositioningEpilepsyCentral Nervous System NeoplasmsAntineoplastic AgentsHumansAnimalsEndoplasmic Reticulum StressMetabolic ReprogrammingEpigenesis, GeneticUnfolded Protein ResponseTumor Microenvironment

Stichwörter der Autor:innen

antiepileptic drugscentral nervous system tumorsdrug repurposingendoplasmic reticulum stressepigenetic regulationion homeostasismetabolic reprogrammingtumor immune microenvironment

Substanzen

AnticonvulsantsAntineoplastic Agents

Autor:innen und Institutionen

  • Sino-German Neuro-Oncology Molecular Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan 430030, China.

ORCID-Profile: Haochen Zhao, Ting Lei

Förderung

  • National Natural Science Foundation of China
  • Beijing Celarts Bioscience Group Co. Ltd.

Zitieren

APA

Zhao, H., Jiang, Q., Wang, Q., Wang, Z., Huang, Y., & Lei, T. (2026). Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy. Cells. https://doi.org/10.3390/cells15050409

Vancouver

Zhao H, Jiang Q, Wang Q, Wang Z, Huang Y, Lei T. Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy. Cells. 2026. doi:10.3390/cells15050409

BibTeX
@article{Zhao2026,
  author = {Zhao, Haochen and Jiang, Qian and Wang, Quanji and Wang, Zihan and Huang, Yimin and Lei, Ting},
  title = {Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15050409}
}
Kostenlos starten →